IRS1 and cancer: Among them, the insulin-like growth factor 1 receptor/insulin receptor substrate 1 (IGF1R/IRS1) signaling pathway contributes to the transformation and growth of malignant cells, and enhances the migration and invasiveness of tumor cells in several types of cancers, including OC7–10.